Used as a key intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors for cancer treatment. Its boron-containing group enables Suzuki-Miyaura cross-coupling reactions, allowing efficient construction of complex drug molecules. Commonly employed in research settings to design and optimize bioactive compounds targeting neurological disorders and inflammatory diseases. Also utilized in medicinal chemistry for late-stage functionalization, improving drug candidates' potency and selectivity.